ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,465Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1383

$1.25M Total Retail Price of All Prescriptions

Rank: 31 out of 1383

865 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 865 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 865 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 20,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,121 913 S3 1 1
FUROSEMIDE 970 870 2 7
SIMVASTATIN 829 760 3 2
OMEPRAZOLE 695 607 4 5
POTASSIUM CHLORIDE 651 592 5 12
TRAZODONE HCL 638 549 6 36
LEVOTHYROXINE SODIUM 596 535 7 4
LISINOPRIL 583 488 8 3
AMLODIPINE BESYLATE 526 487 9 6
SERTRALINE HCL 449 401 10 21
DONEPEZIL HCL 426 426 11 35
WARFARIN SODIUM 419 402 12 13
METOPROLOL TARTRATE 369 325 13 9
GABAPENTIN 336 224 14 11
MIRTAZAPINE 332 328 15 51
CITALOPRAM HBR 330 274 16 15
CYMBALTA 280 194 17 53
METFORMIN HCL 265 203 18 8
RISPERIDONE 260 252 19 71
PRAVASTATIN SODIUM 255 216 20 14
FAMOTIDINE 255 223 20 61
METOPROLOL SUCCINATE 255 228 20 29
MELOXICAM 248 228 23 20
HYDROCHLOROTHIAZIDE 233 193 24 10
CARVEDILOL 209 191 25 24
ATENOLOL 196 164 26 16
ZOLPIDEM TARTRATE 168 116 27 17
CLONIDINE HCL 167 151 28 44
POLYETHYLENE GLYCOL 3350 165 154 29 64
LOVASTATIN 155 122 30 22
IPRATROPIUM-ALBUTEROL 151 142 31 138
PANTOPRAZOLE SODIUM 150 107 32 32
ALENDRONATE SODIUM 149 134 33 37
ATORVASTATIN CALCIUM 144 122 34 18
PROMETHAZINE HCL 143 127 R 35 56
ADVAIR DISKUS 142 133 36 63
TAMSULOSIN HCL 140 122 37 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 100 38 27
VENLAFAXINE HCL ER 134 81 39 102
NAMENDA 133 133 40 49
CLOPIDOGREL 132 91 41 28
LANTUS 132 114 41 50
DIOVAN 130 121 43 58
PAROXETINE HCL 130 117 43 55
QUETIAPINE FUMARATE 127 110 45 70
TRAMADOL HCL 123 101 46 25
LOSARTAN POTASSIUM 120 85 47 23
ABILIFY 118 92 48 178
PLAVIX 115 97 49 43
PREDNISONE 115 79 49 40
SPIRIVA 113 105 51 45
HYDRALAZINE HCL 110 92 52 86
JANUVIA 108 100 53 85
GLIMEPIRIDE 106 93 54 31
CYCLOBENZAPRINE HCL 103 54 R 55 69
CRESTOR 102 73 56 34
OXYCODONE HCL-ACETAMINOPHEN 102 85 S2 56 81
RANITIDINE HCL 99 65 58 19
ALLOPURINOL 99 82 58 33
FENOFIBRATE 97 77 60 65
ROPINIROLE HCL 95 68 61 79
TRICOR 94 76 62 125
CIPROFLOXACIN HCL 94 85 62 54
NEXIUM 87 48 64 26
OLANZAPINE 86 86 65 164
ESCITALOPRAM OXALATE 86 67 65 99
LEVOFLOXACIN 86 70 65 88
NYSTATIN 85 67 68 132
AZITHROMYCIN 81 68 69 41
ESTRADIOL 80 49 R 70 96
AMIODARONE HCL 80 79 70 188
FLUOXETINE HCL 79 76 72 52
FINASTERIDE 79 79 72 121
EXELON 76 76 74 117
PRIMIDONE 73 67 75 207
DIVALPROEX SODIUM 73 64 75 78
DIGOXIN 73 73 75 59
ENALAPRIL MALEATE 72 69 78 75
VESICARE 68 57 79 182
MORPHINE SULFATE ER 68 45 S2 79 77
BENAZEPRIL HCL 67 67 81 38
ZETIA 67 56 81 101
AMITRIPTYLINE HCL 66 52 R 83 57
BUPROPION HCL SR 65 45 84 194
DOXYCYCLINE HYCLATE 65 57 84 94
LOSARTAN-HYDROCHLOROTHIAZIDE 65 55 84 60
TOPIRAMATE 64 47 87 208
METFORMIN HCL ER 64 64 87 47
CARBIDOPA-LEVODOPA 63 48 89 108
OXYBUTYNIN CHLORIDE 62 45 90 115
LEVETIRACETAM 61 42 91 134
FLUTICASONE PROPIONATE 59 49 92 39
NIFEDIPINE ER 59 58 92 126
SPIRONOLACTONE 58 57 94 67
DILTIAZEM HCL 58 52 94 203
DIOVAN HCT 58 55 94 103
GLYBURIDE 58 51 R 94 46
SEROQUEL 56 51 98 130
METOCLOPRAMIDE HCL 56 21 98 127
HUMALOG 56 40 98 176
ISOSORBIDE MONONITRATE ER 56 56 98 66
AVODART 55 55 102 249
AMLODIPINE BESYLATE-BENAZEPRIL 54 38 103 68
PROPRANOLOL HCL 54 54 103 129
MEGESTROL ACETATE 54 53 R 103 170
PHENYTOIN SODIUM EXTENDED 53 41 106 137
DOXAZOSIN MESYLATE 53 53 106 120
OXYCODONE-ACETAMINOPHEN 52 46 S2 108 107
RIVASTIGMINE 51 51 109 239
LYRICA 50 36 110 72
WELCHOL 50 50 110 260
VENTOLIN HFA 50 33 110 93
CLOTRIMAZOLE-BETAMETHASONE 50 33 110 205
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 43 110 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.